NDC 16714-889-01 - ERTAPENEM SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16714-889
- Requested NDC
- 16714-889-01
- Package NDCs from labels
- 16714-889-01, 16714-889-10
- Manufacturer
- NorthStar RxLLC | Gland Pharma Limited
- Effective date
- 2025-12-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ERTAPENEM SODIUM - NorthStar RxLLC | Gland Pharma Limited | NorthStar RxLLC | Gland Pharma Limited | 2025-12-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16714-889-01 | ERTAPENEM SODIUM | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 5 | |
| 16714-889-10 | ERTAPENEM SODIUM | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16714-889-01 | EA - Each | 16714-889 | adcf31ab-b851-4b6b-8f6f-0b238dd3eeb7 | 1 | 2021-10-08 |
| 16714-889-10 | EA - Each | 16714-889 | 16bccce1-41b8-40c0-8513-0198f16169ac | 1 | 2021-10-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | a5eedf57-2783-b3d0-e053-2a95a90a9ff5 | 2024-02-22 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 76131655-3a87-feac-e053-2991aa0a82a1 | 2024-01-28 | Warnings, Adverse reactions | 8MDF5V39QO |
| N03 EXCHEM | ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR | Apex Energetics Inc. | ba73a050-9a5d-1549-e053-2a95a90a62aa | 2024-01-08 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Pharma Nobis, LLC | e42f674b-1a70-6a3c-e053-2995a90afa72 | 2023-12-22 | Warnings | 8MDF5V39QO |
| HEB Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | H. E. Butt Grocery Company | 9e502bd0-8042-8674-e053-2995a90a3d15 | 2023-12-18 | Warnings | 8MDF5V39QO |
| Medis Sodium Bicarbonate | SODIUM BICARBONATE | Humco Holding Group, Inc | 5da32469-58fc-14b1-e053-2a91aa0a74c4 | 2023-12-15 | Warnings | 8MDF5V39QO |
| Ertapenem | ERTAPENEM SODIUM | Apotex Corp | 468105b9-48b3-4477-82c7-e7fb92460e28 | 2023-12-13 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
| INON | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE, SODIUM BICARBONATE | Sato Pharmaceutical Co., Ltd. | e86d9c57-c877-49f1-a405-95a9a226ccf3 | 2023-12-04 | Warnings | 8MDF5V39QO |
| Ertapenem | ERTAPENEM SODIUM | Savior Lifetec Corporation | c4da28cb-6725-4fa1-a7b0-e84f408fb36b | 2023-11-27 | Warnings, Adverse reactions | 1734683 2T90KE67L0 |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | d89406d3-4356-4a8c-acc1-89efe1d27010 | 2023-11-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 09cf38c2-0b44-eca1-e063-6294a90a72d8 | 2023-11-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| omeprazole sodium bicarbonate | OMEPRAZOLE SODIUM BICARBONATE | Cipla USA Inc. | 9cdde58a-ae8a-451f-92cf-cab178e4ba92 | 2023-11-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | APNAR PHARMA LP | e206c240-55c2-2d00-e053-2a95a90a1779 | 2023-10-21 | Boxed warning, Warnings | 8MDF5V39QO |
| Omeprazole/Sodium Bicarbonate | OMEPRAZOLE | Strides Pharma Science Limited | cf6d293e-d70d-443e-8292-d693e93aab55 | 2023-09-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | OMNIVIUM PHARMACEUTICALS LLC. | aea54f8d-1cdd-4a5c-a2f7-7317ae4c8fbc | 2023-08-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | c6b5f808-4a49-1303-9711-badb022ecd70 | 2023-07-19 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | 619cb558-84e5-43ea-91e9-28c764f9f9c0 | 2023-06-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 7a2d8dab-750f-43c1-933c-4169a840c60c | 2023-06-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | b620938d-ab2d-0934-e053-2a95a90a8483 | 2023-05-23 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | d1636b56-ad83-4439-e053-2a95a90a135e | 2023-05-02 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.